Haleon (HLNCF) Equity Average (2022 - 2025)

Haleon (HLNCF) recorded quarterly Equity Average of $21.3 billion in Q4 2025, up 114.01% on a QoQ basis from $10.0 billion in Q4 2022.

Haleon (HLNCF) Equity Average (2022 - 2025) Analysis & Trends

Haleon has disclosed Equity Average across 2 years of filings, most recently posting $21.3 billion for Q4 2025.

Quarterly Equity Average changed N/A year-over-year to $21.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.3 billion (changed N/A YoY) and the FY2025 annual result came in at $21.2 billion, up 2.04% from the prior year.
Equity Average climbed to $21.3 billion in Q4 2025, from $10.0 billion in the prior quarter.
Over five years, Equity Average peaked at $21.3 billion in Q4 2025 and troughed at $10.0 billion in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	8.07 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	3.32 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	6.50 Bn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	409.63 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	3.33 Bn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	6.52 Bn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	1.79 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	493.55 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	1.15 Bn
10	Haleon	-	-	-	21.34 Bn

Download Data

Date	Value
Dec 31, 2025	21.34 Bn
Dec 31, 2022	9.97 Bn